BiosparQ, a paradigm shift in medical microbiologyGerold de Valk, Dec 13th 2012

1

Introducing BiosparQ BV

13-04-2023 2

• TNO spin-off company, 2009 (Leiden Bio Science Park)• 3 staff (applied physics, high tech equipment)• 6 M€ series A funding, 2012 (Dutch informal investor)

Our vision

• A paradigm shift in medical microbiology

Better and safer patient careMuch lower cost

13-04-2023 Company Confidential 3

Intake Diagnosis Treatment After care

Microbiology in 2009

13-04-2023 Company Confidential 4

Sample collection

Pure culture Analysis

Microbiology in 2012

Sample collection

Pure culture Analysis

13-04-2023 Company Confidential 5

Microbiology paradigm shift

13-04-2023 Company Confidential 6

Sample collection Analysis

Requirements

• Faster (minutes instead of hours/days)• Better (polymicrobial infections, quantitative data) • Fieldable (no laboratory infrastructure needed)• Affordable• Easy to use

Radical innovation, shaping a new future for medical microbiology

13-04-2023 Company Confidential 7

How?

Single cell MALDI TOF mass spectrometry

13-04-2023 Company Confidential 8

Development status

13-04-2023 Company Confidential 9

13-04-2023 10

Thank you